Healthcare Reform for Irish Patients
Our Vision
is that all Irish Patients can afford and access the medicines they need to get well, stay well and live well.
About Us
We are dedicated to affordable access to medicine
Medicines for Ireland is a pharmaceutical industry body committed to affecting real change and reforms to help ensure that patients across Ireland have access the medicines they need at affordable prices.
Since its foundation in 2016, Medicines for Ireland has been promoting the benefits of the increased use of non-patent medicines in Ireland.
Our members are the suppliers of the majority of medicine in Ireland to the HSE and patients directly.
Latest Reports
Infographics
Resources
Resources
State Spending
State Spending
Healthcare Spending
Health Expenditure
Life Expentancy
Life Expectancy
Our Goals
As an organisation, our core objective is to improve the way Ireland procures and supplies medicines to help expand patient access to affordable, lifesaving and life-enhancing treatment.
- Enhance access to safe, high-quality medicines for patients across Ireland at an affordable price.
- Safeguard the supply of medicines to Ireland by helping to ensure supply chains remain secure and reliable.
- Innovate our approach to acquiring, supplying, and distributing medicines nationwide with the dual objective of pushing down costs and delivering greater equality of access for patients.
- Inform key stakeholders of the specific and wider benefits associated with the increased usage of off-patent medicines.
News and Articles
Medicines for Ireland welcomes Agreement in Principle reached with the State on the Pricing and Supply of Medicines
New agreement set to unlock earlier access to generic, biosimilar and value-added medicines tostrengthen supply chains, secure access for Irish patients, and deliver value for
Medicines for Ireland announces Managing Director of Clonmel Healthcare, Donagh O’Leary as new Vice Chairperson
Generic, biosimilar and value-added medicines industry leadership reinforced as it prepares for the next framework agreement on pricing and supply of medicines and responds to
European Urban Waste Water Treatment Directive set to significantly impact supply of generic medicines in Ireland
Patient access to medicines at risk due to the disproportionate impact of the UWWTD Extended Producer Responsibility (EPR) scheme on generic medicine suppliers Medicines for
Over €700,000 needlessly spent on duplicate communications to healthcare professionals since 2022, according to MFI Members
Generic, biosimilar and value added medicines industry call for transition to digital-first communications to improve environmental impact and end wasteful duplication of resources Medicines for
Contact Us
Medicines for Ireland
Iconic Offices – The Greenway,
Block C,
Ardilaun Court,
112-114 St Stephen’s Green,
Dublin 2, D02 TD28
